Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib

The prognosis of advanced gastrointestinal stromal tumors (GISTs) was dramatically improved in the era of imatinib. Cytoreduction surgery was advocated as an additional treatment for advanced GISTs, especially when patients having poor response to imatinib or developing resistance to it. However, th...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Medicine (Baltimore)
المؤلفون الرئيسيون: Chang, Shih-Chun, Liao, Chien-Hung, Wang, Shang-Yu, Tsai, Chun-Yi, Chiang, Kun-Chun, Cheng, Chi-Tung, Yeh, Ta-Sen, Chen, Yen-Yang, MA, Ming-Chun, Liu, Chien-Ting, Yeh, Chun-Nan
التنسيق: Artigo
اللغة:Inglês
منشور في: Wolters Kluwer Health 2016
الموضوعات:
5700
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616552/
https://ncbi.nlm.nih.gov/pubmed/26091448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001014
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة